BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 17075831)

  • 1. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
    Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
    Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation.
    Banine F; Bartlett C; Gunawardena R; Muchardt C; Yaniv M; Knudsen ES; Weissman BE; Sherman LS
    Cancer Res; 2005 May; 65(9):3542-7. PubMed ID: 15867346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
    Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
    Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression.
    Reisman DN; Strobeck MW; Betz BL; Sciariotta J; Funkhouser W; Murchardt C; Yaniv M; Sherman LS; Knudsen ES; Weissman BE
    Oncogene; 2002 Feb; 21(8):1196-207. PubMed ID: 11850839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells.
    Vachtenheim J; Ondrusová L; Borovanský J
    Biochem Biophys Res Commun; 2010 Feb; 392(3):454-9. PubMed ID: 20083088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian chromatin remodeling complex SWI/SNF is essential for enhanced expression of the albumin gene during liver development.
    Inayoshi Y; Miyake K; Machida Y; Kaneoka H; Terajima M; Dohda T; Takahashi M; Iijima S
    J Biochem; 2006 Feb; 139(2):177-88. PubMed ID: 16452305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of BRG1 and BRM proteins in prostatic cancer].
    Liu XB; Sun AJ; Wang C; Chen LR
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):591-4. PubMed ID: 21092585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
    Glaros S; Cirrincione GM; Muchardt C; Kleer CG; Michael CW; Reisman D
    Oncogene; 2007 Oct; 26(49):7058-66. PubMed ID: 17546055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines.
    Watanabe H; Mizutani T; Haraguchi T; Yamamichi N; Minoguchi S; Yamamichi-Nishina M; Mori N; Kameda T; Sugiyama T; Iba H
    Oncogene; 2006 Jan; 25(3):470-9. PubMed ID: 16247481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRG1 loss in MiaPaCa2 cells induces an altered cellular morphology and disruption in the organization of the actin cytoskeleton.
    Rosson GB; Bartlett C; Reed W; Weissman BE
    J Cell Physiol; 2005 Nov; 205(2):286-94. PubMed ID: 15887247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.
    Reisman DN; Sciarrotta J; Wang W; Funkhouser WK; Weissman BE
    Cancer Res; 2003 Feb; 63(3):560-6. PubMed ID: 12566296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and epigenetic alterations of BRG1 promote oral cancer development.
    Gunduz E; Gunduz M; Ouchida M; Nagatsuka H; Beder L; Tsujigiwa H; Fukushima K; Nishizaki K; Shimizu K; Nagai N
    Int J Oncol; 2005 Jan; 26(1):201-10. PubMed ID: 15586241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brm transactivates the telomerase reverse transcriptase (TERT) gene and modulates the splicing patterns of its transcripts in concert with p54(nrb).
    Ito T; Watanabe H; Yamamichi N; Kondo S; Tando T; Haraguchi T; Mizutani T; Sakurai K; Fujita S; Izumi T; Isobe T; Iba H
    Biochem J; 2008 Apr; 411(1):201-9. PubMed ID: 18042045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours.
    Bock VL; Lyons JG; Huang XX; Jones AM; McDonald LA; Scolyer RA; Moloney FJ; Barnetson RS; Halliday GM
    Br J Dermatol; 2011 Jun; 164(6):1221-7. PubMed ID: 21564052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.
    Fukuoka J; Fujii T; Shih JH; Dracheva T; Meerzaman D; Player A; Hong K; Settnek S; Gupta A; Buetow K; Hewitt S; Travis WD; Jen J
    Clin Cancer Res; 2004 Jul; 10(13):4314-24. PubMed ID: 15240517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SWI/SNF-Brg1 regulates self-renewal and occupies core pluripotency-related genes in embryonic stem cells.
    Kidder BL; Palmer S; Knott JG
    Stem Cells; 2009 Feb; 27(2):317-28. PubMed ID: 19056910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state.
    Yamamichi N; Inada K; Ichinose M; Yamamichi-Nishina M; Mizutani T; Watanabe H; Shiogama K; Fujishiro M; Okazaki T; Yahagi N; Haraguchi T; Fujita S; Tsutsumi Y; Omata M; Iba H
    Cancer Res; 2007 Nov; 67(22):10727-35. PubMed ID: 18006815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
    Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
    Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
    Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
    BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRG1 expression is increased in human cutaneous melanoma.
    Lin H; Wong RP; Martinka M; Li G
    Br J Dermatol; 2010 Sep; 163(3):502-10. PubMed ID: 20491765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.